Cutting-edge “precision medicine” has great potential to advance the diagnosis, treatment and ultimate prevention of different forms of diabetes, an international coalition of scientists reports in a sweeping assessment of the state of the field around the world.
Name that Humira biosimilar: Inside the complicated process to brand the newest versions of AbbVie’s drug
Seven new drugs launched last week, all with resounding similarity — and all trying to capture a piece of the lucrative market for AbbVie’s Humira.
July 12, 2023